About Northway Biotech US

Prof. Vladas Bumelis is the Founder of Northway Biotech and currently serves as Chairman of the company’s Board and Advisory Board.  With extensive experience in the pharmaceutical and biotech industries, he previously held key positions such as General Manager of Sicor Biotech UAB (now Teva Pharmaceutical Industries Ltd.), Chairman of the Board for Biofa and Biotechna, and served as Chairman of the Board and General Manager of the Institute of Applied Enzymology in Lithuania.

Prof. Bumelis is the author of 157 scientific publications and 32 inventions. Notable accolades include being named CEO of the year in Lithuania in 2012 and receiving the Lithuanian Science Prize in 2004 for his pioneering work in the development and production of recombinant proteins. In 2020, he was honored with the Officer's Cross Award of the Order "For Merit to Lithuania."  Prof. Bumelis holds a Ph.D. and MSc in Chemistry, along with a Ph.D. in Biotechnology from Vilnius University. 

Vladas has a Ph.D. in chemistry, as well as a Ph.D. in biotechnology from Vilnius University, Lithuania.

André holds a Ph.D. in biochemistry and has more than 25 years of experience in the biopharmaceutical industry, having worked for global companies like Sanofi-Aventis and DSM/Patheon. For more than 22 years, André has specialized in Business Development for CDMOs with a focus on process development and cGMP manufacturing of biologicals.

Konstantin Kazarian is a seasoned business development leader in the CDMO space, with a robust scientific foundation in life sciences and 25 years of combined academic and industry experience. After earning his Ph.D. in Protein Biochemistry, he completed postdoctoral research in protein crystallography in the United States and Italy. Throughout his career, he has held roles of increasing responsibility at leading U.S. and European CDMOs, with a strong focus on biologics and gene therapy development, GMP manufacturing, project management, and strategic partnerships. Konstantin is driven by a commitment to operational excellence, delivering tailored, efficient solutions that streamline development timelines and accelerate time-to-market for clients across the biopharmaceutical sector.

Cullen Wargo is an experienced business development leader in the CDMO space with a robust background in vaccine manufacturing and quality control. After earning his bachelor's in microbiology, he entered industry working on Influenza, COVID-19, and Virus Like Particle products. Over his career, he has held roles of increasing responsibility in Quality Control and Business Development. He has a solid track record of establishing strategic partnerships within the biologics and drug product space. Cullen is committed to a right first-time mentality, cultural and operational excellence, and creating value for customers to suit their needs and the needs of their patients.

Todd Ireland is an experienced commercial leader in the lifesciences industry with over 30 years in a variety of technical and commercialroles. A Chemical Engineer by training, hestarted his career with a number of technical roles in process and productdevelopment as well as applications support. He advanced into global roles, building partnerships across commercial,supply chain and innovation initiatives. Todd brings a spirit of creativity and collaboration to support hisclients and drive their programs forward.